GLP-1 Receptor Agonists and Gastrointestinal Adverse Events-Reply

JAMA. 2024 Mar 12;331(10):885-886. doi: 10.1001/jama.2024.0049.

Authors

Ramin Rezaeianzadeh¹, Mohit Sodhi¹, Mahyar Etminan²

Affiliations

¹ Faculty of Medicine, University of British Columbia, Vancouver, Canada.
² Department of Medicine, University of British Columbia, Vancouver, Canada.

PMID: 38470387
DOI: 10.1001/jama.2024.0049

No abstract available

Publication types

Letter
Comment

MeSH terms

Gastrointestinal Diseases* / chemically induced
Glucagon-Like Peptide-1 Receptor Agonists* / adverse effects
Humans

Substances

Glucagon-Like Peptide-1 Receptor Agonists